A detailed history of O'Shaughnessy Asset Management, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 72,235 shares of COLL stock, worth $2.14 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
72,235
Previous 63,600 13.58%
Holding current value
$2.14 Million
Previous $2.05 Million 36.35%
% of portfolio
0.03%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$31.4 - $39.07 $271,139 - $337,369
8,635 Added 13.58%
72,235 $2.79 Million
Q2 2024

Aug 14, 2024

BUY
$31.36 - $39.99 $560,246 - $714,421
17,865 Added 39.06%
63,600 $2.05 Million
Q1 2024

May 13, 2024

BUY
$31.23 - $40.91 $877,563 - $1.15 Million
28,100 Added 159.34%
45,735 $1.78 Million
Q4 2023

Feb 09, 2024

BUY
$21.16 - $30.8 $129,626 - $188,680
6,126 Added 53.23%
17,635 $542,000
Q3 2023

Nov 13, 2023

BUY
$21.23 - $24.28 $30,571 - $34,963
1,440 Added 14.3%
11,509 $257,000
Q2 2023

Aug 11, 2023

SELL
$21.06 - $24.0 $156,307 - $178,128
-7,422 Reduced 42.43%
10,069 $216,000
Q1 2023

May 12, 2023

BUY
$23.0 - $29.88 $402,293 - $522,631
17,491 New
17,491 $419,000
Q4 2021

Feb 11, 2022

SELL
$17.5 - $21.35 $28,910 - $35,270
-1,652 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$19.25 - $26.1 $61,965 - $84,015
-3,219 Reduced 66.08%
1,652 $39,000
Q4 2020

Feb 11, 2021

SELL
$17.83 - $22.29 $66,077 - $82,606
-3,706 Reduced 43.21%
4,871 $98,000
Q3 2020

Nov 12, 2020

SELL
$15.78 - $20.82 $24,916 - $32,874
-1,579 Reduced 15.55%
8,577 $179,000
Q2 2020

Aug 13, 2020

SELL
$15.49 - $23.51 $18,727 - $28,423
-1,209 Reduced 10.64%
10,156 $178,000
Q1 2020

May 13, 2020

BUY
$13.89 - $25.45 $157,859 - $289,239
11,365 New
11,365 $186,000

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.01B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.